Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation
- Author
- KREUZ, Wolfhart1 ; GILL, Joan C2 ; ROTHSCHILD, Chantal3 ; MANCO-JOHNSON, Marilyn J4 ; LUSHER, Jeanne M5 ; KELLERMANN, Elke6 ; GORINA, Eduard7 ; LARSON, Peter J7
[1] The Center of Pediatrics III, Department of Hematology, Oncology and Hemostaseology, Johann Wolfgang Goethe-University Hospital, Frankfurt am Main, Germany
[2] Blood Center of Southeastern Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, United States
[3] Hôpital Necker, Centre de l'Hemophilie F. Josso, Paris, France
[4] Department of Pediatrics, University of Colorado Health Sciences Center, Denver, Colorado, United States
[5] Children's Hospital of Michigan, Detroit, Michigan, United States
[6] Bayer Vital GmbH Biological Products, Leverkusen, Germany
[7] Bayer HealthCare, Biological Products Division, Research Triangle Park, North Carolina, United States
International Kogenate-FS Study Group, International - Source
Thrombosis and haemostasis. 2005, Vol 93, Num 3, pp 457-467, 11 p ; ref : 32 ref
- CODEN
- THHADQ
- ISSN
- 0340-6245
- Scientific domain
- Cardiology, blood circulation, phlebology; Hematology
- Publisher
- Schattauer, Stuttgart
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- FVIII inhibitor Haemophilia A PUPs pediatric
- Keyword (fr)
- Enfant Exploration clinique Facteur antihémophilique A Grave Hémophilie A Inhibiteur International Protéine recombinante Pédiatrie Saccharose Traitement Coagulopathie Homme Hémopathie Maladie héréditaire
- Keyword (en)
- Child Clinical investigation Factor VIII Severe Hemophilia A Inhibitor International Recombinant protein Pediatrics Sucrose Treatment Coagulopathy Human Hemopathy Genetic disease
- Keyword (es)
- Niño Exploración clínica Factor antihemofílico A Grave Hemofilia A Inhibidor Internacional Proteína recombinante Pediatría Sacarosa Tratamiento Coagulopatía Hombre Hemopatía Enfermedad hereditaria
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A04 Molecular and cellular biology / 002A04I Blood coagulation. Blood cells
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19C Platelet diseases and coagulopathies
- Discipline
- Blood diseases Molecular and cell biology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 16585484
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1160/TH03-10-0643 
https://dx.doi.org/10.1160/TH03-10-0643
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1160\/TH03-10-0643\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Thrombosis and haemostasis\";s:9:\"\u0000*\u0000stitle\";s:15:\"Thromb. haemost\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"93\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"457\";s:8:\"\u0000*\u0000epage\";s:3:\"467\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-6245\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KREUZ\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfhart\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"GILL, Joan C\";i:1;s:19:\"ROTHSCHILD, Chantal\";i:2;s:24:\"MANCO-JOHNSON, Marilyn J\";i:3;s:16:\"LUSHER, Jeanne M\";i:4;s:16:\"KELLERMANN, Elke\";i:5;s:14:\"GORINA, Eduard\";i:6;s:15:\"LARSON, Peter J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THHADQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:10:\"Schattauer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1160\/TH03-10-0643\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Thrombosis and haemostasis\";s:9:\"\u0000*\u0000stitle\";s:15:\"Thromb. haemost\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"93\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"457\";s:8:\"\u0000*\u0000epage\";s:3:\"467\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-6245\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KREUZ\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfhart\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"GILL, Joan C\";i:1;s:19:\"ROTHSCHILD, Chantal\";i:2;s:24:\"MANCO-JOHNSON, Marilyn J\";i:3;s:16:\"LUSHER, Jeanne M\";i:4;s:16:\"KELLERMANN, Elke\";i:5;s:14:\"GORINA, Eduard\";i:6;s:15:\"LARSON, Peter J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THHADQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:10:\"Schattauer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:20:\"10.1160\/TH03-10-0643\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1160\/TH03-10-0643\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Thrombosis and haemostasis\";s:9:\"\u0000*\u0000stitle\";s:15:\"Thromb. haemost\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"93\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"457\";s:8:\"\u0000*\u0000epage\";s:3:\"467\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-6245\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KREUZ\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfhart\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"GILL, Joan C\";i:1;s:19:\"ROTHSCHILD, Chantal\";i:2;s:24:\"MANCO-JOHNSON, Marilyn J\";i:3;s:16:\"LUSHER, Jeanne M\";i:4;s:16:\"KELLERMANN, Elke\";i:5;s:14:\"GORINA, Eduard\";i:6;s:15:\"LARSON, Peter J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THHADQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:10:\"Schattauer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:20:\"10.1160\/TH03-10-0643\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:9:\"\u0000*\u0000jtitle\";s:26:\"Thrombosis and haemostasis\";s:9:\"\u0000*\u0000stitle\";s:15:\"Thromb. haemost\";s:7:\"\u0000*\u0000date\";s:4:\"2005\";s:9:\"\u0000*\u0000volume\";s:2:\"93\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"457\";s:8:\"\u0000*\u0000epage\";s:3:\"467\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0340-6245\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"KREUZ\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfhart\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:12:\"GILL, Joan C\";i:1;s:19:\"ROTHSCHILD, Chantal\";i:2;s:24:\"MANCO-JOHNSON, Marilyn J\";i:3;s:16:\"LUSHER, Jeanne M\";i:4;s:16:\"KELLERMANN, Elke\";i:5;s:14:\"GORINA, Eduard\";i:6;s:15:\"LARSON, Peter J\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"THHADQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:207:\"Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A : Results of an international clinical investigation\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:10:\"Schattauer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
